| Irritable Bowel Syndrome |
1 |
1 |
| Fecal Transplant |
0 |
0.99 |
| Microbiome |
0 |
0.86 |
| Biologic Therapy |
0 |
0.81 |
| Clostridium Difficile Infection |
0 |
0.81 |
| Fatigue |
0 |
0.22 |
| Bacteria |
0 |
0.18 |
| Quality of Life |
0 |
0.18 |
| Transplantation |
0 |
0.18 |
| Abdominal Pain |
0 |
0.1 |
| Abdomen |
0 |
0.09 |
| Abdominal Bloating |
0 |
0.09 |
| Adverse Effects |
0 |
0.09 |
| Body Mass Index |
0 |
0.09 |
| Clinical Research |
0 |
0.09 |
| Diet |
0 |
0.09 |
| Meta-Analysis |
0 |
0.09 |
| Patient Safety |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Vaginal Delivery |
0 |
0.06 |
| Pain Management |
0 |
0.05 |
| Diversity |
0 |
0.04 |
| Duodenum |
0 |
0.04 |
| Exercise |
0 |
0.04 |
| Grant |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Minerals |
0 |
0.04 |
| Pain |
0 |
0.04 |
| Remission |
0 |
0.04 |
| Retransplantation |
0 |
0.04 |
| Vagina |
0 |
0.04 |
| Vitamin |
0 |
0.04 |
| Antibiotics |
0 |
0.03 |
| Pregnancy |
0 |
0.03 |
| Social Determinants of Health |
0 |
0.03 |